Tower Research Capital (TRC)’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-376
Closed -$10.9K 5394
2025
Q4
$10.9K Sell
376
-1,186
-76% -$22.5K ﹤0.01% 3689
2025
Q3
$12.1K Buy
1,562
+295
+23% +$2.21K ﹤0.01% 3818
2025
Q2
$9.38K Buy
1,267
+220
+21% +$1.93K ﹤0.01% 3993
2025
Q1
$9.01K Buy
1,047
+689
+192% +$10.6K ﹤0.01% 3834
2024
Q4
$12.8K Buy
358
+183
+105% +$9.47K ﹤0.01% 3584
2024
Q3
$8.25K Sell
175
-1,455
-89% -$64.2K ﹤0.01% 3969
2024
Q2
$81.9K Buy
1,630
+1,597
+4,839% +$115K ﹤0.01% 2727
2024
Q1
$3.67K Sell
33
-948
-97% -$94.2K ﹤0.01% 4820
2023
Q4
$56.9K Sell
981
-951
-49% -$38.3K ﹤0.01% 3047
2023
Q3
$61.4K Buy
1,932
+1,636
+553% +$77.8K ﹤0.01% 2369
2023
Q2
$24.4K Sell
296
-642
-68% -$93.9K ﹤0.01% 3207
2023
Q1
$96K Sell
938
-530
-36% -$74.4K ﹤0.01% 1912
2022
Q4
$215K Buy
1,468
+12
+0.8% +$2.03K 0.01% 1254
2022
Q3
$246K Buy
1,456
+1,116
+328% +$181K ﹤0.01% 1716
2022
Q2
$39K Buy
340
+3
+0.9% +$282 ﹤0.01% 3123
2022
Q1
$34K Sell
337
-457
-58% -$53.4K ﹤0.01% 3037
2021
Q4
$124K Buy
794
+446
+128% +$86.8K ﹤0.01% 2084
2021
Q3
$82K Buy
348
+115
+49% +$33.6K ﹤0.01% 2568
2021
Q2
$79K Sell
233
-107
-31% -$40.5K ﹤0.01% 2619
2021
Q1
$137K Buy
340
+313
+1,159% +$152K ﹤0.01% 2327
2020
Q4
$18K Sell
27
-245
-90% -$136K ﹤0.01% 3934
2020
Q3
$126K Sell
272
-108
-28% -$54.6K ﹤0.01% 2955
2020
Q2
$223K Buy
+380
New +$130K 0.01% 1704
2020
Q1
Sell
-31
Closed -$4K 3575
2019
Q4
$4K Sell
31
-272
-90% -$19.9K ﹤0.01% 2796
2019
Q3
$12K Buy
303
+169
+126% +$12.3K ﹤0.01% 2829
2019
Q2
$14K Buy
134
+72
+116% +$8.48K ﹤0.01% 2378
2019
Q1
$8K Sell
62
-375
-86% -$47.2K ﹤0.01% 2810
2018
Q4
$45K Buy
437
+286
+189% +$45.2K ﹤0.01% 1350
2018
Q3
$38K Buy
151
+63
+72% +$21.1K ﹤0.01% 1933
2018
Q2
$39K Buy
+88
New +$38.6K ﹤0.01% 1996
2017
Q4
Sell
-12
Closed -$5K 3872
2017
Q3
$5K Buy
+12
New +$4.73K ﹤0.01% 3321

Other funds holding MRSN